Health
CervicalCheck controversy could ‘derail’ screening programmes, WHO body warns
The International Agency for Research on Cancer has expressed concern that the situation in Ireland could have a ‘ripple effect’ across Europe
A World Health Organisation (WHO) body has warned that public trust and litigation issues arising from the CervicalCheck controversy could “derail” screening programmes in Ireland and have a “ripple effect” across Europe.
Speaking to the Business Post, Partha Basu, deputy head of early detection, prevention and infections at the International Agency for Research on Cancer (IARC), a WHO body, said that Ireland has very well run screening programmes, but that missed cancers were a certainty ...